Constance Delaugerre
- Virology top 0.2%
- HIV Research and Treatment 131
- Infectious Diseases top 0.2%
- HIV/AIDS drug development and treatment 114
- HIV/AIDS Research and Interventions 91
- SARS-CoV-2 and COVID-19 Research 11
- Hepatology top 1%
- Hepatitis C virus research 36
- Epidemiology top 2%
- Hepatitis B Virus Studies 28
- Liver Disease Diagnosis and Treatment 17
- HIV, Drug Use, Sexual Risk 13
- Emergency Medicine top 2%
- Co-authors
- Jean‐Michel MolinaVincent CálvezChristine KatlamaMarie‐Laure ChaixChristine RouziouxSarah MaylinAnne‐Geneviève MarcelinFrançois Simon
- Journals
- The Lancet (2 papers)The Journal of Experimental Medicine (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- FranceUnited StatesIvory Coast
In The Last Decade
Constance Delaugerre
199 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 113
- Virology 2.6k
- Infectious Diseases 3.2k
- Hepatology 625
- Epidemiology 1.3k
- Emergency Medicine 309
Countries citing papers authored by Constance Delaugerre
This map shows the geographic impact of Constance Delaugerre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constance Delaugerre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constance Delaugerre more than expected).
Fields of papers citing papers by Constance Delaugerre
This network shows the impact of papers produced by Constance Delaugerre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constance Delaugerre. The network helps show where Constance Delaugerre may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Constance Delaugerre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 25 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 80 | |
| 13 | 2021 | 4 | |
| 14 | 2021 | 19 | |
| 15 | 2021 | 4 | |
| 16 | Incidence of HIV infection with daily or on-demand oral prep with TDF/FTC in france | 2021 | 8 |
| 17 | 2021 | 16 | |
| 18 | 2012 | 4 | |
| 19 | Barrière génétique à la résistance des antirétroviraux : Le point sur le raltégravir, premier inhibiteur d’intégrase | 2010 | 5 |
| 20 | 2006 | 2 |
About Constance Delaugerre
Constance Delaugerre is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 206 papers that have together received 4.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (131 papers), HIV/AIDS drug development and treatment (114 papers), HIV/AIDS Research and Interventions (91 papers), Hepatitis C virus research (36 papers), Hepatitis B Virus Studies (28 papers), Liver Disease Diagnosis and Treatment (17 papers), HIV, Drug Use, Sexual Risk (13 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). The work is most often cited by research in Virology (2.6k citations), Infectious Diseases (3.2k citations) and Hepatology (625 citations). Constance Delaugerre has collaborated with scholars based in France, United States and Ivory Coast. Frequent co-authors include Jean‐Michel Molina, Vincent Cálvez, Christine Katlama, Marie‐Laure Chaix, Christine Rouzioux, Sarah Maylin, Anne‐Geneviève Marcelin, François Simon, Jade Ghosn and Gilles Peytavin. Their work appears in journals such as The Lancet, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.